Advanced Inorganic Nanosystems for Skin Drug Delivery. 2018

E Carazo, and A Borrego-Sánchez, and F García-Villén, and R Sánchez-Espejo, and P Cerezo, and C Aguzzi, and C Viseras
Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, University of Granada, Campus of Cartuja, 18071 s/n, Granada, Spain.

On/into/through the skin drug delivery represents an attractive alternative for the oral route, providing local and/or systemic drug delivery. Due to its complex and well-organised structure, most of the drugs show difficulties to penetrate the human skin. Therefore, enormous efforts have been invested to develop intelligent drug delivery systems overcoming the skin barrier with particular emphasis on increasing therapeutic activity and minimizing undesirable side-effects. Most of these strategies require the use of singular materials with new properties. In particular, and on the basis of their inherent properties, including biocompatibility, biodegradability and relative low-cost, inorganic nanoparticles are ideal candidates for the development of skin drug delivery systems. This review provides an updated and comprehensive overview of the state of the art in the trends towards skin drug delivery with a particular focus in the attractive alternative offered by inorganic-based nanosystems.

UI MeSH Term Description Entries
D008903 Minerals Native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions. They may occur as individual crystals or may be disseminated in some other mineral or rock. (Grant & Hackh's Chemical Dictionary, 5th ed; McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Mineral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
D012871 Skin Diseases Diseases involving the DERMIS or EPIDERMIS. Dermatoses,Skin and Subcutaneous Tissue Disorders,Dermatosis,Skin Disease
D016503 Drug Delivery Systems Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity. Drug Targeting,Delivery System, Drug,Delivery Systems, Drug,Drug Delivery System,Drug Targetings,System, Drug Delivery,Systems, Drug Delivery,Targeting, Drug,Targetings, Drug
D045663 Quantum Dots Nanometer sized fragments of semiconductor crystalline material which emit PHOTONS. The wavelength is based on the quantum confinement size of the dot. They can be embedded in MICROBEADS for high throughput ANALYTICAL CHEMISTRY TECHNIQUES. Nanocrystals, Semiconductor,Semiconductor Nanocrystals,Semiconductor Nanoparticles,Dot, Quantum,Dots, Quantum,Nanocrystal, Semiconductor,Nanoparticle, Semiconductor,Nanoparticles, Semiconductor,Quantum Dot,Semiconductor Nanocrystal,Semiconductor Nanoparticle
D053758 Nanoparticles Nanometer-sized particles that are nanoscale in three dimensions. They include nanocrystaline materials; NANOCAPSULES; METAL NANOPARTICLES; DENDRIMERS, and QUANTUM DOTS. The uses of nanoparticles include DRUG DELIVERY SYSTEMS and cancer targeting and imaging. Nanocrystalline Materials,Nanocrystals,Material, Nanocrystalline,Materials, Nanocrystalline,Nanocrystal,Nanocrystalline Material,Nanoparticle
D053768 Metal Nanoparticles Nanoparticles produced from metals whose uses include biosensors, optics, and catalysts. In biomedical applications the particles frequently involve the noble metals, especially gold and silver. Metal Nanocrystals,Metallic Nanocrystals,Metallic Nanoparticles,Metal Nanocrystal,Metal Nanoparticle,Metallic Nanocrystal,Metallic Nanoparticle,Nanocrystal, Metal,Nanocrystal, Metallic,Nanocrystals, Metal,Nanocrystals, Metallic,Nanoparticle, Metal,Nanoparticle, Metallic,Nanoparticles, Metal,Nanoparticles, Metallic

Related Publications

E Carazo, and A Borrego-Sánchez, and F García-Villén, and R Sánchez-Espejo, and P Cerezo, and C Aguzzi, and C Viseras
September 2022, Molecules (Basel, Switzerland),
E Carazo, and A Borrego-Sánchez, and F García-Villén, and R Sánchez-Espejo, and P Cerezo, and C Aguzzi, and C Viseras
June 2014, Drug delivery,
E Carazo, and A Borrego-Sánchez, and F García-Villén, and R Sánchez-Espejo, and P Cerezo, and C Aguzzi, and C Viseras
January 2015, Advances in experimental medicine and biology,
E Carazo, and A Borrego-Sánchez, and F García-Villén, and R Sánchez-Espejo, and P Cerezo, and C Aguzzi, and C Viseras
November 2021, Nanoscale,
E Carazo, and A Borrego-Sánchez, and F García-Villén, and R Sánchez-Espejo, and P Cerezo, and C Aguzzi, and C Viseras
January 2012, Pharmaceutical research,
E Carazo, and A Borrego-Sánchez, and F García-Villén, and R Sánchez-Espejo, and P Cerezo, and C Aguzzi, and C Viseras
October 2022, Micromachines,
E Carazo, and A Borrego-Sánchez, and F García-Villén, and R Sánchez-Espejo, and P Cerezo, and C Aguzzi, and C Viseras
August 2018, Langmuir : the ACS journal of surfaces and colloids,
E Carazo, and A Borrego-Sánchez, and F García-Villén, and R Sánchez-Espejo, and P Cerezo, and C Aguzzi, and C Viseras
May 2007, Expert opinion on biological therapy,
E Carazo, and A Borrego-Sánchez, and F García-Villén, and R Sánchez-Espejo, and P Cerezo, and C Aguzzi, and C Viseras
April 2019, Chemical communications (Cambridge, England),
E Carazo, and A Borrego-Sánchez, and F García-Villén, and R Sánchez-Espejo, and P Cerezo, and C Aguzzi, and C Viseras
January 2017, Current drug metabolism,
Copied contents to your clipboard!